🔎 Trials Near Me

Pradžia › Opinis kolitas › Merilendas

Opinis kolitas klinikiniai tyrimai Merilendas

13 tyrimai dėl Opinis kolitas ieško dalyvių vietose Merilendas.

Miestai Merilendas

Oficialus tyrimo tekstas (anglų kalba)

Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease

  • National Institutes of Health Clinical Center, Bethesda
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07619547

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  • Capital Digestive Care, Chevy Chase
  • Woodholme Gastroenterology, Glen Burnie
Renkami dalyviai4 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-30 · NCT06581328

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  • Site 011, Glen Burnie
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-29 · NCT07012395

Immune Regulation in Ulcerative Colitis or Crohn s Disease

  • National Institutes of Health Clinical Center, Bethesda
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
1 Day – 75 Years · Visoms lytims · Atnaujinta 2026-09-28 · NCT00001184

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

  • Chevy Chase Clinical Research, Chevy Chase
  • Woodholme Gastroenterology Associates, Glen Burnie
Renkami dalyviai3 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07196748

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Capital Digestive Care - Chevy Chase, Chevy Chase
Renkami dalyviai3 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-24 · NCT06937086

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
  • National Cancer Institute Developmental Therapeutics Clinic, Bethesda
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT03816345

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

  • Capital Digestive Care - MGG Group - Chevy Chase Clinical Research, Chevy Chase
Renkami dalyviai4 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-21 · NCT06095128

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • Mercy Medical Center, Baltimore - Site Number: 8400117, Baltimore
  • Mid-Atlantic GI Research, LLC - Site Number: 8400106, Greenbelt
Renkami dalyviai3 fazė
Amžius nuo 16 iki 80 · Visoms lytims · Atnaujinta 2026-08-20 · NCT07184996

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

  • Mercy Medical Center, Baltimore
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-05 · NCT07237516

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

  • MGG Group Co., Inc., Chevy Chase Clinical Research, Chevy Chase
  • Woodholme Gastroenterology Associates PA, Glen Burnie
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 64 · Visoms lytims · Atnaujinta 2026-07-09 · NCT06398626

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

  • Woodholme Gastroenterology Associates, Glen Burnie
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-05-22 · NCT06764615

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

  • Capital Digestive Care, Chevy Chase
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-05-08 · NCT06750731

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.